Experimental autoimmune myocarditis is provoked by immunization with cardiac myosin. This animal model finally develops into dilated cardiomyopathy through repetitive myosin injections.
tis, namely EAM,was provoked in Lewis rats by immunization using cardiac myosin. The features were quite different from those of viral infection (2) . The whole figure and pathomechanismof this model is very unique as mentioned previously (3, 4) . The histology of EAMis remarkably characterized with enormous cell infiltrate including multinuclear giant cells and broad myocardial necrosis, which are dominantly detected in the epicardial site of every ventricular wall ( Fig. 1 ). Through the transfer experiment, this myocarditis is mediated by T cell autoimmunity (5) . The pathomechanism of this disease is explained as follows (4) . Myosin fragments as causative epitopes, cajdiac dendritic cells as antigen presenters, and myosin autoreactive T cells as effectors are the main elements in this process. The cardiac myosin activates the local lymph nodal myosin reactive Thl T cells from ThO T cells and the T cells move to the heart. And as they can encounter the same antigen in the myocardium, these T cells are greatly expanded through dendritic mediation. Consequently, they release interferon y and IL-2. These cytokines then activate macrophageswhich allow them to release IL-1(3, TNFa and NO. The amount of NOdischarge provokes serious inflammation. Seven weeks later, the T cells gradually shift from Thl to Th2. This shift diminishes the inflammation. Interestingly, after several months have passed, such a cycle can be reproduced by repetitive immunization with the cardiac myosin (6) . Accordingly, it has been proven that this model develops into autoimmunecardiomyopathy at the animal level.
Epitopes of Cardiac Myosin Heavy Chain proached it using the anchor protein theory. The peptide consists of 17 amino acids and is located in the light meromyosin. Concerning the former epitope, to determine the myocarditogenecity, three experiments had to be undertaken. The first one was done by digesting fragmental peptides from naive cardiac myosin. Through this method, we detected the 96 amino acids as mentioned above, Inomata's peptide. Next, artificially synthesized peptides were employed. In the case of Inomata's peptide, we failed to further identify exact site of the epitope through these artificial products, because there it occurred nothing in spite of immunization with synthesized peptides. But in Wegmann's peptide, we succeeded in provoking myocarditis using artificial ones. Thus, we started the third experiment in Inomata's peptide. The recombinant type of cardiac myosin was chosen to determine the myocardito-genecity (9) . The peptide was induced in E coli, to which a part of the myosin gene had been formerly ligated to a protein expression vector. So far, some distinguished investigators have emphasized that the cardiac myosin chain a is stronger than the P in myocarditogenecity (10) (11) (12) .
However, using recombinant myosin, we could demonstrate no difference in initiating and promoting myocarditis between the two (13) . We attempted to determine the C-terminal in every amino acid using recombinant myosin immunization. Wealso approached the N-terminal.
Finally, we could determine the exact amino sequence and its site. In fact, the total number of amino acids was 30 from 1,124 E to 1,153 E. Thus, the site is called Kohno's peptide. In comparison with the standard size of other T cellmediated autoimmunediseases, the length of the epitope was much longer. Thereafter, we added several experiments; We To date, only two fragments have been nominated as myocarditogenic epitopes in the rat. A fragment located in segment 2 of the rod portion and consisting of 96 amino acids was discovered by Inomata et al (7), and another fragment was found by Wegmann et al (8) . This peptide consists of 17 amino acids and is located in the light meromyosin. It is called the CM2 peptide.
by RP-HPLC, then we acquired two major peptides; we called them peak-4 (from 1,111 E to 1,132 K) and peak-5
(from 1,140 L to 1,166 K). Although we immunized rats with these peptides, nothing happened. But, when we conjugated the former peptide, peak-4, to the latter one, peak-5, using glutaraldehyde, it began to function as an epitope. Interestingly, in the synthesized peptide study, only peak-5 showed high antigen productivity.
To understand the phenomenon, we propose the hypothesis as shown in Fig. 4 .
Namely, peak-5 may activate B-cells. This activation probably enhances antigen-presenting activity. And, the stimuli may cause the epitope to spread including peak 4 and, finally the epitope mayactivate the autoreactive T cell and provoke autoimmune myocarditis. On the other hand, Wegmann's peptide is not so complicated and it is very illustrative to T cell immunity. The peptide may be digested and presented by antigen presenting cells. The T cell triad seemed to induce autoimmunemyocarditis. This difference was reflected on the specificity of autoreactive T cell activation (Fig. 5) . In the presence of dendritic cells, the T cells isolated from whole myosin immunizedrats were tested. In the case of Wegmann's CM2, the T cells were specifically activated by the peptide in comparison with the controls. On the other hand, in Kohno's peptide, the cells did not indicate specificity against the antigen stimulations. These findings support the possibility that our epitope requires a specific characteristic for antigen presenting.
C omments
The recombinant cardiac myosin, Kohno' Figure 3 . Structure and function of the myocarditogenic epitope. The C-terminal of this epitope was determined in every amino acid by using recombinant myosin immunization. Wealso approached the N-terminal. Finally, we could determine the exact amino sequence and its site. The total number of amino acids was 30 from 1,124 E to 1,153 E. As shownhere, the recombinant peptide could provoke the disease and circulating antibodies against the peptide. However, when the peptide was cleaved in the middle by Lys-endoproteinase, nothing happened. But, when we conjugated the former peptide, peak-4, to the latter one, peak-5, using glutaraldehyde, it began to function as an epitope again.
Myocardia l Figure 4 . Function and structure of Kohno's peptide. Probably, peak-5 activates B-cells. This activation enhances antigenpresenting activity. And, the stimuli maycause the epitope to spread including peak 4 and, finally the epitope may activate autoreactive T cells and induce autoimmunemyocarditis.
clearly understand why this myocarditogenic segment needs such long peptides. In previous reports, some myocarditogenic peptides had been indicated in other rodent models of autoimmunemyo- Figure 5 . Specificity of autoreactive T cell activation. The difference between the two peptides was detected by on the specificity of autoreactive T cell activation. The autoreactive T cells were easily activated by Wegmann's peptide but not by Kohno's. pathy in humanbeings easier and more accurate.
